| Dr Alana S Cozier, MD | |
|
1 Medical Park Blvd, Bristol, TN 37620-7430 | |
| (423) 844-1121 | |
| (423) 844-6626 |
| Full Name | Dr Alana S Cozier |
|---|---|
| Gender | Female |
| Speciality | Neurology |
| Experience | 14 Years |
| Location | 1 Medical Park Blvd, Bristol, Tennessee |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1821387721 | NPI | - | NPPES |
| Facility Name | Location | Facility Type |
|---|---|---|
| Wellmont Bristol Regional Medical Center | Bristol, TN | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellmont Medical Associates Inc | 8123291739 | 405 |
| Wellmont Medical Associates Inc | 8123291739 | 405 |
News Archive
Scientists have known for some time that most major groups of complex animals appeared in the fossils record during the Cambrian Explosion, a seemingly rapid evolutionary event that occurred 542 million years ago.
CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today the enrollment of the first patient in its PerClot Investigational Device Exemption (IDE) clinical trial, the Company's pivotal clinical trial to gain approval to commercialize PerClot in the U.S.
Relief from low vitamin D levels could now be just a spray away thanks to an award-winning vitamin D oral spray that could help boost the vitamin D levels of those with chronic heart failure, resulting in improved heart function, according to a recent study.
Knee injuries are among the top five reasons people visit an orthopedic surgeon for treatments, which include 719,000 total knee replacements performed annually in the United States. Now, new research reveals underlying biomechanics that may be involved in meniscus fibrocartilage function as well as dysfunction and could guide novel treatments for some of the most debilitating and costly orthopedic problems in the U.S., including meniscus tears and age-related joint degeneration.
Results from ZETA, a phase III study in patients with advanced medullary thyroid cancer (MTC), showed that treatment with the investigational drug vandetanib significantly extended Progression Free Survival (PFS), the primary endpoint of the study, by demonstrating a 54% reduction in the rate of progression compared to placebo.
› Verified 8 days ago
| Entity Name | Wellmont Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780986257 PECOS PAC ID: 8123291739 Enrollment ID: O20111026000909 |
News Archive
Scientists have known for some time that most major groups of complex animals appeared in the fossils record during the Cambrian Explosion, a seemingly rapid evolutionary event that occurred 542 million years ago.
CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today the enrollment of the first patient in its PerClot Investigational Device Exemption (IDE) clinical trial, the Company's pivotal clinical trial to gain approval to commercialize PerClot in the U.S.
Relief from low vitamin D levels could now be just a spray away thanks to an award-winning vitamin D oral spray that could help boost the vitamin D levels of those with chronic heart failure, resulting in improved heart function, according to a recent study.
Knee injuries are among the top five reasons people visit an orthopedic surgeon for treatments, which include 719,000 total knee replacements performed annually in the United States. Now, new research reveals underlying biomechanics that may be involved in meniscus fibrocartilage function as well as dysfunction and could guide novel treatments for some of the most debilitating and costly orthopedic problems in the U.S., including meniscus tears and age-related joint degeneration.
Results from ZETA, a phase III study in patients with advanced medullary thyroid cancer (MTC), showed that treatment with the investigational drug vandetanib significantly extended Progression Free Survival (PFS), the primary endpoint of the study, by demonstrating a 54% reduction in the rate of progression compared to placebo.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Alana S Cozier, MD 105 W Stone Dr Ste 6a, Kingsport, TN 37660-3256 Ph: (423) 408-7220 | Dr Alana S Cozier, MD 1 Medical Park Blvd, Bristol, TN 37620-7430 Ph: (423) 844-1121 |
News Archive
Scientists have known for some time that most major groups of complex animals appeared in the fossils record during the Cambrian Explosion, a seemingly rapid evolutionary event that occurred 542 million years ago.
CryoLife, Inc., a leading medical device and tissue processing company focused on cardiac and vascular surgery, announced today the enrollment of the first patient in its PerClot Investigational Device Exemption (IDE) clinical trial, the Company's pivotal clinical trial to gain approval to commercialize PerClot in the U.S.
Relief from low vitamin D levels could now be just a spray away thanks to an award-winning vitamin D oral spray that could help boost the vitamin D levels of those with chronic heart failure, resulting in improved heart function, according to a recent study.
Knee injuries are among the top five reasons people visit an orthopedic surgeon for treatments, which include 719,000 total knee replacements performed annually in the United States. Now, new research reveals underlying biomechanics that may be involved in meniscus fibrocartilage function as well as dysfunction and could guide novel treatments for some of the most debilitating and costly orthopedic problems in the U.S., including meniscus tears and age-related joint degeneration.
Results from ZETA, a phase III study in patients with advanced medullary thyroid cancer (MTC), showed that treatment with the investigational drug vandetanib significantly extended Progression Free Survival (PFS), the primary endpoint of the study, by demonstrating a 54% reduction in the rate of progression compared to placebo.
› Verified 8 days ago
Steven Wesley Morgan, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3183 W State St, Suite 1201, Bristol, TN 37620 Phone: 423-764-0987 Fax: 423-652-2512 | |
David Albert Brenner, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-1121 | |
Dr. George Harold Naramore, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 26 Midway Street, Bristol, TN 37620 Phone: 423-989-4500 Fax: 423-989-4582 | |
Dr. Howard Leftin, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Medical Park Blvd, Bristol, TN 37620 Phone: 423-844-1121 | |
Shawn Keith Nelson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3183 W State St, Suite 1201, Bristol, TN 37620 Phone: 423-764-0987 Fax: 423-652-2512 | |
Douglas Paul Williams, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3183 W State St, Suite 1201, Bristol, TN 37620 Phone: 423-764-1987 Fax: 423-652-2512 | |
Earl Keith Wilson, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3183 W State St, Suite 1201, Bristol, TN 37620 Phone: 423-764-0987 Fax: 423-652-2512 |